Cerus Corporation
NASDAQ: CERS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- William Greenman
- Employees
- 614
- Headquarters
- Concord, United States
- IPO year
- 1997
- Market cap
- $529.0M
- Website
- https://www.cerus.com
Loading CERS…
Loading profile data…Frequently asked questions about CERS
What does Cerus Corporation (CERS) do?
Cerus Corporation operates as a biotechnology firm dedicated to advancing and marketing the INTERCEPT Blood System. This proprietary technology significantly enhances the safety of transfusable blood components by neutralizing biological threats, thereby reducing the risk of blood-borne pathogens. The company's product line includes INTERCEPT sy...
Where does CERS trade?
Cerus Corporation (CERS) trades on the NASDAQ Global Market.
What sector is CERS in?
Cerus Corporation (CERS) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Cerus Corporation?
William Greenman is the chief executive officer of Cerus Corporation (CERS).
Where is Cerus Corporation headquartered?
Cerus Corporation is headquartered in United States.
Does CERS pay a dividend?
Cerus Corporation (CERS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CERS go public?
Cerus Corporation (CERS) completed its initial public offering in 1997.